Back
ESC Professional Premium Access

Pacemaker implantation due to cardiac conduction disease in patients with subsequent cardiac sarcoidosis may be a marker of early disease and is associated with adverse 5-year clinical outcome

Session: Evaluation and treatment of conduction disease in 2022
Topic: Atrioventricular (AV) Block
Speaker: Doctor A. Slattman (Lund, SE)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Anna Slattman

Skane University Hospital, Lund (Sweden)
0 follower

7 more presentations in this session

Results of permanent lead implantation at the His bundle without the use of an electrophysiological unit

Speaker: Associate Professor C. Israel (Bielefeld, DE)

Access
Abstract
Slides
Like
Thumbnail

Patient reported symptoms in emergency health care service in patients with complete atrioventricular block

Speaker: Doctor C. Bang (Soeborg, DK)

Access
Abstract
Slides
Like
Thumbnail

Etiologies and predictors for cardiac implantable electronic device implantation in young patients hospitalized for complete atrioventricular block

Speaker: Doctor G. Margolis (Hadera, IL)

Access
Abstract
Slides
Like
Thumbnail

Type 2 diabetes is associated with higher risk of 3rd degree atrioventricular block: a Danish nationwide registry study

Speaker: Doctor S. Haxha (Hilleroed, DK)

Access
Abstract
Slides
Like
Thumbnail

A novel scoring system to predict cardiac device implantation in patients presenting with syncope

Speaker: Doctor A. Khan (Birmingham, GB)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Evaluation and treatment of conduction disease in 2022

Speakers: Doctor A. Slattman, Associate Professor C. Israel, Doctor C. Bang, Doctor G. Margolis, Doctor S. Haxha...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources